Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does BLINATUMOMAB Cause Hepatic enzyme increased? 66 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 66 reports of Hepatic enzyme increased have been filed in association with BLINATUMOMAB (BLINCYTO). This represents 0.7% of all adverse event reports for BLINATUMOMAB.

66
Reports of Hepatic enzyme increased with BLINATUMOMAB
0.7%
of all BLINATUMOMAB reports
8
Deaths
25
Hospitalizations

How Dangerous Is Hepatic enzyme increased From BLINATUMOMAB?

Of the 66 reports, 8 (12.1%) resulted in death, 25 (37.9%) required hospitalization, and 1 (1.5%) were considered life-threatening.

Is Hepatic enzyme increased Listed in the Official Label?

Yes, Hepatic enzyme increased is listed as a known adverse reaction in the official FDA drug label for BLINATUMOMAB.

What Other Side Effects Does BLINATUMOMAB Cause?

Pyrexia (1,064) Acute lymphocytic leukaemia recurrent (977) Cytokine release syndrome (952) Off label use (590) Death (588) Neurotoxicity (530) Drug ineffective (345) Headache (335) Neutropenia (265) Febrile neutropenia (262)

What Other Drugs Cause Hepatic enzyme increased?

METHOTREXATE (9,857) ADALIMUMAB (8,693) TOCILIZUMAB (7,691) ETANERCEPT (7,481) ABATACEPT (7,397) RITUXIMAB (7,247) LEFLUNOMIDE (7,173) INFLIXIMAB (6,778) HYDROXYCHLOROQUINE (6,555) TOFACITINIB (6,269)

Which BLINATUMOMAB Alternatives Have Lower Hepatic enzyme increased Risk?

BLINATUMOMAB vs BLONANSERIN BLINATUMOMAB vs --BLOOD-COAGULATION FACTOR VIII FUSION PROTEIN WITH IMMUNOGLOBULIN G1 , ,-BIS WITH IMMUNOGLOBULIN G1 BLINATUMOMAB vs BOCEPREVIR BLINATUMOMAB vs BOCOCIZUMAB BLINATUMOMAB vs BONIVA

Related Pages

BLINATUMOMAB Full Profile All Hepatic enzyme increased Reports All Drugs Causing Hepatic enzyme increased BLINATUMOMAB Demographics